Literature DB >> 10568903

Responsiveness and sensitivity to change of SLE disease activity measures.

M Corzillius1, P Fortin, G Stucki.   

Abstract

The ability of outcome measures to detect change over time is critical for their usefulness in clinical trials. Two concepts are applied in the assessment of evaluative instruments: We endorse the recommendation that a distinction be made between sensitivity and responsiveness. Sensitivity to change refers to the capacity of instruments to measure change statistically. Sensitivity statistics relate the magnitude of observed change to some measure of variablity and are essentially signal-to-noise ratios. Responsiveness addresses the detection of clinically relevant change. The methodology is still evolving but a common approach has been to correlate the observed change in scores with external standards that are believed to indicate clinical relevance (e.g., physician- or patient-based transition scales). Sensitivity to change and responsiveness of SLE activity indices have been addressed in a small number of studies. These indicate that the most widely used systems (SLEDAI. SLAM, BILAG) are sensitive to change although the available evidence does not allow preference for one instrument over the others. Little research has been done on the responsiveness of these measures. This article reviews the methodological concepts in measuring clinical change and summarizes reports on sensitivity and responsiveness of lupus activity scores.

Entities:  

Mesh:

Year:  1999        PMID: 10568903     DOI: 10.1191/096120399680411416

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  A new high-flexion knee scoring system to eliminate the ceiling effect.

Authors:  Sang-Eun Na; Chul-Won Ha; Choong-Hee Lee
Journal:  Clin Orthop Relat Res       Date:  2011-11-29       Impact factor: 4.176

2.  Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change.

Authors:  C O Anyanwu; D F Fiorentino; L Chung; C Dzuong; Y Wang; J Okawa; K Carr; K J Propert; V P Werth
Journal:  Br J Dermatol       Date:  2015-08-11       Impact factor: 9.302

Review 3.  The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: A comprehensive review.

Authors:  S Ahmed; K L Chen; V P Werth
Journal:  Semin Arthritis Rheum       Date:  2020-01-11       Impact factor: 5.532

4.  Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.

Authors:  Jinoos Yazdany; Edward H Yelin; Pantelis Panopalis; Laura Trupin; Laura Julian; Patricia P Katz
Journal:  Arthritis Rheum       Date:  2008-01-15

5.  Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis.

Authors:  R Q Klein; C A Bangert; M Costner; M K Connolly; A Tanikawa; J Okawa; M Rose; S S Fakharzadeh; D Fiorentino; L A Lee; R D Sontheimer; L Taylor; A B Troxel; V P Werth
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

6.  Clinically important improvement in the WOMAC and predictor factors for response to non-specific non-steroidal anti-inflammatory drugs in osteoarthritic patients: a prospective study.

Authors:  Ihsane Hmamouchi; Fadoua Allali; Latifa Tahiri; Hamza Khazzani; Leila El Mansouri; Sanae Ali Ou Alla; Redouane Abouqal; Najia Hajjaj-Hassouni
Journal:  BMC Res Notes       Date:  2012-01-23

7.  Consensus on measurement properties and feasibility of performance tests for the exercise and sport sciences: a Delphi study.

Authors:  Sam Robertson; Peter Kremer; Brad Aisbett; Jacqueline Tran; Ester Cerin
Journal:  Sports Med Open       Date:  2017-01-05

Review 8.  Determining an Appropriate Outcome Measure in Neurosurgical Research: Investigating Meaningful, Valid, and Practical Metrics.

Authors:  Christopher Louie; Erin N D'Agostino; David Han; Timothy C Ryken
Journal:  Cureus       Date:  2019-09-09

9.  Managing Fatigue in Parkinson's Disease: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Neda Alizadeh; Tanya L Packer; Ingrid Sturkenboom; Gail Eskes; Grace Warner
Journal:  Can J Occup Ther       Date:  2022-03-15       Impact factor: 1.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.